Filing Details
- Accession Number:
- 0001510964-19-000074
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-12 16:05:11
- Reporting Period:
- 2019-11-08
- Accepted Time:
- 2019-11-12 16:05:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1510964 | Cv Sciences Inc. | CVSI | Pharmaceutical Preparations (2834) | 800944970 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1611860 | D Joseph Dowling | 10070 Barnes Canyon Road San Diego CA 92121 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-11-08 | 15,000 | $1.65 | 15,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- These shares were purchased in multiple transactions at a price of $1.65 per share.
- The reporting person undertakes to provide CV Sciences, Inc., any security holder of CV Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares purchased at the price set forth in footnote (1) to this Form 4.